Zibara V, Sen F, Scordo M, Falchi L, et al. Successful brentuximab vedotin and nivolumab therapy of multiply refractory diffuse large B-cell lymphoma with Hodgkin features. Leuk Lymphoma 2022 Sep 18:1-4. doi: 10.1080/10428194.2022.2113528.
PMID: 36120859